Evidence map›Paper›PMID 23289753›Full record

ArticleBioscience reports2013

Phosphorylation at Ser²⁶ in the ATP-binding site of Ca²⁺/calmodulin-dependent kinase II as a mechanism for switching off the kinase activity.

Mehtap Yilmaz, Samudra S Gangopadhyay, Paul Leavis, Zenon Grabarek, Kathleen G Morgan

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mehtap Yilmaz*Department of Health Sciences, Boston University, 635 Commonwealth Avenue, Boston, MA 02215, U.S.A.
Samudra S Gangopadhyay
Paul Leavis§Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, U.S.A.
Zenon Grabarek§Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, U.S.A.
Kathleen G Morgan*Department of Health Sciences, Boston University, 635 Commonwealth Avenue, Boston, MA 02215, U.S.A.
Boston Biomedical Research Institute · USBoston University · USBoston Children's Hospital · US

Funding

REGULATION OF CONTRACTION OF BLOOD VESSELSR01HL031704 · NHLBI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MORGAN, KATHLEEN G · 1985 to 2009
$3.7M
Troponin and myosin in regulation of muscle contraction and heart diseaseR01HL091162 · NHLBI · BOSTON BIOMEDICAL RESEARCH INSTITUTE · PI GRABAREK, ZENON · 2009 to 2012
$2.0M
NHLBI NIH HHS HL031704NHLBI NIH HHS HL091162
6 · The paper itself

Abstract

CaMKII (Ca²⁺/calmodulin-dependent kinase II) is a serine/threonine phosphotransferase that is capable of long-term retention of activity due to autophosphorylation at a specific threonine residue within each subunit of its oligomeric structure. The γ isoform of CaMKII is a significant regulator of vascular contractility. Here, we show that phosphorylation of CaMKII γ at Ser²⁶, a residue located within the ATP-binding site, terminates the sustained activity of the enzyme. To test the physiological importance of phosphorylation at Ser²⁶, we generated a phosphospecific Ser²⁶ antibody and demonstrated an increase in Ser²⁶ phosphorylation upon depolarization and contraction of blood vessels. To determine if the phosphorylation of Ser²⁶ affects the kinase activity, we mutated Ser²⁶ to alanine or aspartic acid. The S26D mutation mimicking the phosphorylated state of CaMKII causes a dramatic decrease in Thr²⁸⁷ autophosphorylation levels and greatly reduces the catalytic activity towards an exogenous substrate (autocamtide-3), whereas the S26A mutation has no effect. These data combined with molecular modelling indicate that a negative charge at Ser²⁶ of CaMKII γ inhibits the catalytic activity of the enzyme towards its autophosphorylation site at Thr²⁸⁷ most probably by blocking ATP binding. We propose that Ser²⁶ phosphorylation constitutes an important mechanism for switching off CaMKII activity.

Indexed as

Adenosine TriphosphateAnimalsBinding SitesCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2CalmodulinFerretsMutationPhosphorylationProtein IsoformsSerineSignal TransductionThreonineAdenosine TriphosphateCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2CalmodulinProtein IsoformsSerineThreonine

Identifiers

PMID23289753
PMCPMC3566533
OpenAlexW2153049983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.